Evidence map›Paper›PMID 42614608›Full record

ArticleACS pharmacology & translational science2026

Validation and Clinical Evaluation of an LC-MS/MS Method for Serum Full-Length Parathyroid Hormone 1-84 with Application to Chronic Kidney Disease.

Chunyan Li, Shangqi Yin, Huiru Zhao, Ruichen Liu, Xianglong Zhao, Zhao Zhang, Fan Liu, Jie Yang, Jun Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS pharmacology & translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chunyan LiDepartment of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, 100035 Beijing, China.
Shangqi YinDepartment of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, 100035 Beijing, China.
Huiru ZhaoDepartment of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, 100035 Beijing, China.
Ruichen LiuDepartment of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, 100035 Beijing, China.
Xianglong ZhaoShanghai AB Sciex Analytical Instrument Trading Co., Ltd., 100035 Beijing, China.
Zhao ZhangShanghai AB Sciex Analytical Instrument Trading Co., Ltd., 100035 Beijing, China.
Fan LiuFourth School of Clinical Medicine, Peking University Health Science Center, Peking University, 100035 Beijing, China.ORCID https://orcid.org/0000-0002-9481-0797
Jie YangInstitute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, 100005 Beijing, China.
Jun WuDepartment of Nephrology, Beijing Jishuitan Hospital, Capital Medical University, 100035 Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bone disorderchronic kidney diseaseconventional immunoassaysLCMS/MSparathyroid hormone

Identifiers

PMID42614608
PMCPMC13482879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.